
<?xml version='1.0' encoding='UTF-8'?>
<article>
<front>
<journal-meta>
<journal-id journal-id-type='publisher'>IJRAP</journal-id>
<journal-title>International Journal of Research in Ayurveda and Pharmacy</journal-title>
<issn pub-type='ppub'>2277-4343</issn>
 <publisher>
<publisher-name>Moksha Publishing House </publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type='other'>10.7897/2277-4343.1204130</article-id>
<title-group>
<article-title>A REVIEW ON THE SECOND-GENERATION LIPID CARRIERS: NLC__ampersandsignrsquo;S
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type='author'>
<name>A N Jyothsna Sree *</name>
</contrib>
</contrib-group>
<pub-date>
<month>11</month>
<year>-0001</year>
</pub-date>
<fpage>176</fpage>
<lpage>182</lpage>
<abstract><title>Abstract</title>
Over the past few years, nanostructured lipid carriers became an emerging drug delivery system as lipid drug delivery systems are more focused. Within them, solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have more advantages over other lipid carriers. This article is a cumulation of structure, types, composition, formulation methodologies, drug release from NLCs, various applications of NLCs. The key aspects for promising drug delivery systems are biocompatibility, drug loading capacity, ease of preparation, non-toxicity, and stability.
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>nanostructured lipid carriers</kwd>
<kwd> lipids</kwd>
<kwd> toxicity</kwd>
<kwd> biocompatibility</kwd>
<kwd> surfactants. </kwd>
</kwd-group>
<counts><ref-count count='56635'/><page-count count='79'/></counts>
</article-meta></front><back><ref-list><title>References</title></ref-list></back></article>
